Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04758624 · ClinicalTrials.gov registry record · NA

Elucidating the Temporality of Structural and Functional Connectivity Changes in Essential Tremor After Successful Deep Brain Stimulation to the Dentato-rubro-thalamic Tract

A NA study of Essential Tremor, sponsored by Northwell Health.

Recruiting
Registry status
NA
Development phase
72
Enrollment target
1
Study location

NCT04758624: Recruiting NA study of Essential Tremor, sponsored by Northwell Health.

NCT04758624 is a NA study of Essential Tremor that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 72 participants, below the 401-participant average among 41 other Essential Tremor trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04758624, a NA study of Essential Tremor, is actively recruiting participants, sponsored by Northwell Health.

RECRUITING
Registry status
NA
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to elucidate the structural connectivity of the dentato-rubro-thalamic tract (DRTt) and to detect functional network changes due to DRTt stimulation

Conditions Studied

Interventions

  • DEVICE Deep Brain Stimulation

Study Locations (1)

New York

  • North Shore University Hospital - Manhasset

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2021-12-04
Est. Completion 2026-08-31
Phase NA
Northwell Health

370 total trials

What NCT04758624 shows while recruiting

NCT04758624 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 401-participant average among 41 other Essential Tremor trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Essential Tremor appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation is the first listed.

NCT04758624 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04758624 about?

NCT04758624 is a clinical study titled "Elucidating the Temporality of Structural and Functional Connectivity Changes in Essential Tremor After Successful Deep Brain Stimulation to the Dentato-rubro-thalamic Tract". The purpose of this study is to elucidate the structural connectivity of the dentato-rubro-thalamic tract (DRTt) and to detect functional network changes due to DRTt stimulation

What is the current status of trial NCT04758624?

This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2021-12-04. Estimated completion is 2026-08-31.

What conditions does trial NCT04758624 study?

This clinical trial studies the following conditions: Essential Tremor.

What interventions are being tested in trial NCT04758624?

The interventions under investigation include: Deep Brain Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04758624?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04758624 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Essential Tremor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04758624's enrollment target sits among peer trials

72 20th of 41 higher than 22 of 41 other Essential Tremor trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Essential Tremor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04758624, the US trial registry maintained by the National Library of Medicine. NCT04758624 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.